Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagement.

Michelle L MellionLucienne RoncoCécile L BerendsLisa PaganSander BrooksMichiel Joost van EsdonkEmilie M J van BrummelenAdefowope OdueyungboLorin A ThompsonMichelle HageUmesh A BadrisingShane RainesWilliam G TracewellBaziel van EngelenDiego CadavidGeert J Groeneveld

Published in: British journal of clinical pharmacology (2021)

Clinical trial identifier ToetsingOnline: NL68539.056.18 Nederlands Trials Register NL8000.

Keyphrases

clinical trial
open label
double blind
phase ii
muscular dystrophy
study protocol
phase iii
social media
placebo controlled
early onset
duchenne muscular dystrophy